James M. Youakim

Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome.

S. Peters, E. Berry-Kravis, T. Benke, 2022, Contemporary clinical trials.

Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study

E. Marsh, E. Berry-Kravis, D. Glaze, 2023, Nature Medicine.